Cash flow Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse Other stock markets 04:00:02 2026-01-15 pm EST			5-day change	1st Jan Change
47.14 ^USD	+0.38%		+7.19%	+11.49%

Jan. 15	Globalfoundries Appoints Ganesh Moorthy to Board of Directors, Effective from January 15, 2026	CI
Jan. 12	UBS Adjusts Price Target on Celanese to $50 From $49, Maintains Neutral Rating	MT

b0b695df1eeda4ff7e.sXVn0jNpLliLsjUIXIA_TbcRggCephoajMSkIzy-5WM.1BlSg3ZdQRrih3t8PfRQdIVI2EHL_nRo-ZvQU2bh0inXHVORUTBcLMHfAQ

Published financial data: CELANESE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.66B	8.54B	9.67B	10.94B	10.28B
Total Revenues	5.66B	8.54B	9.67B	10.94B	10.28B
Cost of Goods Sold, Total	4.36B	5.86B	7.29B	8.34B	7.85B
Gross Profit	1.29B	2.68B	2.38B	2.6B	2.43B
Selling General & Admin Expenses, Total	464M	527M	690M	1.14B	1.05B
R&D Expenses	74M	86M	112M	146M	130M
Amortization of Goodwill and Intangible Assets - (IS)	22M	25M	62M	164M	159M
Other Operating Expenses	-1M	-	-	-	-
Other Operating Expenses, Total	559M	638M	864M	1.45B	1.34B
Operating Income	734M	2.04B	1.52B	1.15B	1.09B
Interest Expense, Total	-109M	-91M	-405M	-720M	-676M
Interest And Investment Income	132M	155M	202M	165M	161M
Net Interest Expenses	23M	64M	-203M	-555M	-515M
Income (Loss) On Equity Invest.	134M	146M	220M	102M	196M
Currency Exchange Gains (Loss)	-5M	2M	-2M	-19M	-26M
Other Non Operating Income (Expenses)	5M	-5M	10M	76M	90M
EBT, Excl. Unusual Items	891M	2.25B	1.54B	753M	833M
Restructuring Charges	-43M	5M	6M	-53M	-176M
Merger & Related Restructuring Charges	-	-	-117M	-	-
Gain (Loss) On Sale Of Investments	1.41B	-	-	-	-
Gain (Loss) On Sale Of Assets	-7M	3M	5M	505M	-14M
Asset Writedown	-1M	-2M	-14M	-15M	-1.64B
Legal Settlements	-2M	-	-	-	-
Other Unusual Items	5M	-9M	-	-7M	-
EBT, Incl. Unusual Items	2.25B	2.25B	1.42B	1.18B	-996M
Income Tax Expense	247M	330M	-489M	-790M	510M
Earnings From Continuing Operations	2B	1.92B	1.91B	1.97B	-1.51B
Earnings Of Discontinued Operations	-12M	-22M	-8M	-9M	-8M
Net Income to Company	1.99B	1.9B	1.9B	1.96B	-1.51B
Minority Interest	-7M	-6M	-8M	-4M	-8M
Net Income - (IS)	1.98B	1.89B	1.89B	1.96B	-1.52B
Net Income to Common Incl Extra Items	1.98B	1.89B	1.89B	1.96B	-1.52B
Net Income to Common Excl. Extra Items	2B	1.91B	1.9B	1.97B	-1.51B
Per Share Items
Net EPS - Basic	16.85	16.99	17.48	18.01	-13.93
Basic EPS - Continuing Operations	16.95	17.19	17.55	18.09	-13.86
Basic Weighted Average Shares Outstanding	118M	111M	108M	109M	109M
Net EPS - Diluted	16.75	16.86	17.34	17.92	-13.93
Diluted EPS - Continuing Operations	16.85	17.06	17.41	18	-13.86
Diluted Weighted Average Shares Outstanding	118M	112M	109M	109M	109M
Normalized Basic EPS	4.67	12.6	8.81	4.29	4.69
Normalized Diluted EPS	4.64	12.5	8.74	4.27	4.69
Dividend Per Share	2.48	2.72	2.74	2.8	2.8
Payout Ratio	14.76	16.08	15.68	15.56	-20.17
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.08B	2.42B	1.98B	1.83B	1.8B
EBITA	753M	2.07B	1.57B	1.27B	1.2B
EBIT	734M	2.04B	1.52B	1.15B	1.09B
EBITDAR	1.16B	2.49B	2.07B	1.96B	1.93B
Effective Tax Rate - (Ratio)	10.97	14.68	-34.41	-66.78	-51.2
Current Domestic Taxes	13M	-	54M	8M	79M
Current Foreign Taxes	126M	323M	306M	162M	239M
Total Current Taxes	139M	323M	360M	170M	318M
Deferred Domestic Taxes	308M	-16M	-261M	-178M	-87M
Deferred Foreign Taxes	-200M	23M	-588M	-782M	279M
Total Deferred Taxes	108M	7M	-849M	-960M	192M
Normalized Net Income	550M	1.4B	955M	467M	513M
Interest Capitalized	8M	12M	18M	37M	30M
Interest on Long-Term Debt	23M	34M	29M	54M	38M
Non-Cash Pension Expense	-16M	-101M	-8M	64M	22M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	77M	89M	121M	189M	172M
Net Rental Expense, Total	75M	70M	98M	131M	134M
Imputed Operating Lease Interest Expense	17.12M	13.98M	34.31M	54.29M	55.96M
Imputed Operating Lease Depreciation	57.88M	56.02M	63.69M	76.71M	78.04M
Stock-Based Comp., Other (Total)	28M	95M	60M	40M	32M
Total Stock-Based Compensation	28M	95M	60M	40M	32M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	955M	536M	1.51B	1.8B	962M
Short Term Investments	533M	10M	-	-	-
Total Cash And Short Term Investments	1.49B	546M	1.51B	1.8B	962M
Accounts Receivable, Total	792M	1.16B	1.38B	1.24B	1.12B
Other Receivables	450M	506M	675M	541M	493M
Total Receivables	1.24B	1.67B	2.05B	1.78B	1.61B
Inventory	978M	1.52B	2.81B	2.36B	2.28B
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	55M	70M	241M	272M	285M
Total Current Assets	3.76B	3.81B	6.61B	6.22B	5.14B
Gross Property Plant And Equipment	7.45B	7.91B	9.68B	10.09B	10.22B
Accumulated Depreciation	-3.28B	-3.48B	-3.69B	-4.08B	-4.56B
Net Property Plant And Equipment	4.17B	4.43B	6B	6.01B	5.66B
Long-term Investments	820M	823M	1.06B	1.22B	1.22B
Goodwill	1.17B	1.41B	7.14B	6.98B	5.39B
Other Intangibles, Total	319M	735M	4.1B	3.98B	3.64B
Deferred Tax Assets Long-Term	259M	248M	808M	1.68B	1.25B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	411M	521M	547M	524M	555M
Total Assets	10.91B	11.98B	26.27B	26.6B	22.86B
Liabilities
Accounts Payable, Total	797M	1.16B	1.52B	1.51B	1.23B
Accrued Expenses, Total	386M	323M	650M	670M	655M
Short-term Borrowings	65M	264M	800M	358M	108M
Current Portion of Long-Term Debt	482M	502M	481M	1B	1.37B
Current Portion of Leases	66M	62M	108M	113M	102M
Current Income Taxes Payable	-	81M	43M	25M	4M
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	177M	113M	468M	395M	386M
Total Current Liabilities	1.97B	2.5B	4.07B	4.07B	3.85B
Long-Term Debt	3.06B	3.03B	13.23B	12.18B	10.96B
Long-Term Leases	379M	348M	511M	449M	416M
Unearned Revenue Non Current	4M	-	-	-	-
Pension & Other Post Retirement Benefits	643M	558M	411M	457M	396M
Deferred Tax Liability Non Current	509M	555M	1.24B	999M	933M
Other Non Current Liabilities	450M	444M	709M	891M	694M
Total Liabilities	7.01B	7.44B	20.17B	19.04B	17.25B
Additional Paid In Capital	257M	333M	372M	394M	409M
Retained Earnings	8.09B	9.68B	11.27B	12.93B	11.1B
Treasury Stock	-4.49B	-5.49B	-5.49B	-5.49B	-5.49B
Comprehensive Income and Other	-328M	-329M	-518M	-744M	-848M
Total Common Equity	3.53B	4.19B	5.64B	7.09B	5.18B
Minority Interest	369M	348M	468M	461M	434M
Total Equity	3.9B	4.54B	6.1B	7.55B	5.61B
Total Liabilities And Equity	10.91B	11.98B	26.27B	26.6B	22.86B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	114M	108M	108M	109M	109M
ECS Total Common Shares Outstanding	114M	108M	108M	109M	109M
Book Value / Share	30.88	38.78	51.97	65.11	47.33
Tangible Book Value	2.04B	2.04B	-5.61B	-3.86B	-3.85B
Tangible Book Value Per Share	17.88	18.9	-51.72	-35.45	-35.24
Total Debt	4.05B	4.2B	15.13B	14.1B	12.95B
Net Debt	2.56B	3.66B	13.62B	12.29B	11.99B
Debt Equivalent of Unfunded Proj. Benefit Obligation	459M	305M	233M	271M	245M
Debt Equivalent Oper. Leases	600M	560M	784M	1.05B	1.07B
Minority Interest, Total (Incl. Fin. Div)	369M	348M	468M	461M	434M
Equity Method Investments, Total	820M	823M	1.06B	1.22B	1.22B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	251M	435M	786M	593M	560M
Inventories - Work In Process, Total	74M	75M	202M	160M	119M
Inventories - Finished Goods, Total	653M	1.01B	1.82B	1.6B	1.6B
Land - (BS)	53M	48M	291M	260M	240M
Buildings, Total	812M	820M	1.06B	1.08B	1.06B
Machinery, Total	5.4B	5.64B	6.9B	7.16B	7.74B
Full Time Employees	7.66K	8.53K	13.26K	12.41K	12.16K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	11M	10M	15M	12M	16M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.98B	1.89B	1.89B	1.96B	-1.52B
Depreciation & Amortization - CF	332M	353M	406M	561M	593M
Amortization of Goodwill and Intangible Assets - (CF)	19M	22M	53M	121M	117M
Depreciation & Amortization, Total	351M	375M	459M	682M	710M
Amortization of Deferred Charges, Total - (CF)	3M	3M	9M	43M	42M
(Gain) Loss From Sale Of Asset	3M	-5M	-8M	-501M	13M
(Gain) Loss on Sale of Investments - (CF)	-1.41B	-	-	-	-
Asset Writedown & Restructuring Costs	33M	2M	24M	29M	1.71B
(Income) Loss On Equity Investments - (CF)	13M	-34M	-3M	55M	-33M
Stock-Based Compensation (CF)	28M	95M	60M	40M	32M
Net Cash From Discontinued Operations	5M	15M	-28M	-2M	-5M
Other Operating Activities, Total	50M	-96M	-868M	-923M	223M
Change In Accounts Receivable	141M	-396M	218M	105M	92M
Change In Inventories	124M	-367M	-253M	398M	11M
Change In Accounts Payable	-6M	353M	-84M	20M	-234M
Change in Other Net Operating Assets	21M	-78M	399M	-7M	-73M
Cash from Operations	1.34B	1.76B	1.82B	1.9B	966M
Capital Expenditure	-364M	-467M	-543M	-568M	-435M
Cash Acquisitions	-100M	-1.14B	-10.59B	52M	-
Divestitures	21M	27M	48M	480M	-
Investment in Marketable and Equity Securities, Total	1.07B	516M	-	-	-
Other Investing Activities, Total	-39M	-53M	-57M	-98M	-35M
Cash from Investing	592M	-1.12B	-11.14B	-134M	-470M
Short Term Debt Issued, Total	311M	206M	536M	452M	175M
Long-Term Debt Issued, Total	-	990M	10.77B	3B	328M
Total Debt Issued	311M	1.2B	11.3B	3.45B	503M
Short Term Debt Repaid, Total	-753M	-6M	-	-881M	-418M
Long-Term Debt Repaid, Total	-30M	-786M	-526M	-3.66B	-1.03B
Total Debt Repaid	-783M	-792M	-526M	-4.54B	-1.45B
Issuance of Common Stock	-	-	-	-	1M
Repurchase of Common Stock	-650M	-1B	-17M	-	-
Common Dividends Paid	-293M	-304M	-297M	-305M	-307M
Common & Preferred Stock Dividends Paid	-293M	-304M	-297M	-305M	-307M
Other Financing Activities, Total	-56M	-142M	-175M	-63M	-59M
Cash from Financing	-1.47B	-1.04B	10.29B	-1.46B	-1.31B
Foreign Exchange Rate Adjustments	28M	-15M	4M	-12M	-26M
Net Change in Cash	492M	-419M	972M	297M	-843M
Supplemental Items
Cash Interest Paid	120M	105M	122M	780M	701M
Cash Income Tax Paid (Refund)	167M	215M	273M	237M	349M
Levered Free Cash Flow	527M	558M	-151M	1.08B	510M
Unlevered Free Cash Flow	595M	614M	102M	1.53B	932M
Change In Net Working Capital	-118M	669M	830M	-611M	97M
Net Debt Issued / Repaid	-472M	404M	10.78B	-1.09B	-948M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.5	11.16	4.95	2.72	2.75
Return on Total Capital	6.12	15.31	6.32	3.35	3.38
Return On Equity %	59	45.49	35.9	28.89	-22.89
Return on Common Equity	66.2	49.57	38.71	30.94	-24.69
Margin Analysis
Gross Profit Margin %	22.86	31.42	24.6	23.79	23.61
SG&A Margin	8.21	6.17	7.13	10.46	10.21
EBITDA Margin %	19.19	28.34	20.42	16.74	17.49
EBITA Margin %	13.32	24.2	16.22	11.61	11.72
EBIT Margin %	12.98	23.94	15.67	10.5	10.58
Income From Continuing Operations Margin %	35.44	22.47	19.75	18.03	-14.65
Net Income Margin %	35.1	22.14	19.58	17.92	-14.81
Net Avail. For Common Margin %	35.31	22.4	19.66	18	-14.73
Normalized Net Income Margin	9.72	16.41	9.87	4.27	4.99
Levered Free Cash Flow Margin	9.31	6.53	-1.56	9.84	4.96
Unlevered Free Cash Flow Margin	10.52	7.2	1.06	13.95	9.07
Asset Turnover
Asset Turnover	0.55	0.75	0.51	0.41	0.42
Fixed Assets Turnover	1.4	1.99	1.86	1.82	1.76
Receivables Turnover (Average Receivables)	6.89	8.74	7.62	8.34	8.7
Inventory Turnover (Average Inventory)	4.33	4.68	3.37	3.23	3.38
Short Term Liquidity
Current Ratio	1.91	1.52	1.63	1.53	1.34
Quick Ratio	1.38	0.88	0.88	0.88	0.67
Operating Cash Flow to Current Liabilities	0.68	0.7	0.45	0.47	0.25
Days Sales Outstanding (Average Receivables)	53.14	41.75	47.92	43.74	42.08
Days Outstanding Inventory (Average Inventory)	84.58	77.99	108.4	113.06	108.15
Average Days Payable Outstanding	67.08	55.8	56.98	70.07	64.4
Cash Conversion Cycle (Average Days)	70.63	63.94	99.34	86.73	85.83
Long Term Solvency
Total Debt/Equity	103.93	92.66	247.76	186.68	230.91
Total Debt / Total Capital	50.96	48.1	71.24	65.12	69.78
LT Debt/Equity	88.19	74.41	225.01	167.19	202.75
Long-Term Debt / Total Capital	43.25	38.62	64.7	58.32	61.27
Total Liabilities / Total Assets	64.3	62.11	76.76	71.61	75.46
EBIT / Interest Expense	6.73	22.46	3.74	1.6	1.61
EBITDA / Interest Expense	10.64	27.35	5.12	2.72	2.86
(EBITDA - Capex) / Interest Expense	7.3	22.22	3.78	1.94	2.21
Total Debt / EBITDA	3.49	1.69	7.3	7.19	6.7
Net Debt / EBITDA	2.21	1.47	6.57	6.27	6.21
Total Debt / (EBITDA - Capex)	5.09	2.08	9.89	10.11	8.65
Net Debt / (EBITDA - Capex)	3.22	1.81	8.9	8.82	8.01
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-10.2	50.96	13.31	13.1	-6.03
Gross Profit, 1 Yr. Growth %	-19.49	107.42	-11.26	9.37	-6.76
EBITDA, 1 Yr. Growth %	-20.57	122.54	-18.35	-7.76	-2.55
EBITA, 1 Yr. Growth %	-27.18	174.37	-24.06	-19.06	-5.12
EBIT, 1 Yr. Growth %	-27.54	178.47	-25.83	-24.21	-5.31
Earnings From Cont. Operations, 1 Yr. Growth %	131.94	-4.29	-0.42	3.3	-176.33
Net Income, 1 Yr. Growth %	132.98	-4.79	0.21	3.48	-177.65
Normalized Net Income, 1 Yr. Growth %	-25.97	154.76	-31.82	-51.15	9.86
Diluted EPS Before Extra, 1 Yr. Growth %	144.56	1.25	2.05	3.39	-177
Accounts Receivable, 1 Yr. Growth %	-6.82	46.59	18.78	-9.86	-9.82
Inventory, 1 Yr. Growth %	-5.78	55.83	84.25	-16.06	-3.1
Net Property, Plant and Equip., 1 Yr. Growth %	6.51	6.19	35.4	0.15	-5.74
Total Assets, 1 Yr. Growth %	15.12	9.77	119.39	1.24	-14.06
Tangible Book Value, 1 Yr. Growth %	82.07	0.05	-374.73	-31.18	-0.21
Common Equity, 1 Yr. Growth %	40.65	18.8	34.57	25.79	-27.02
Cash From Operations, 1 Yr. Growth %	-7.63	30.83	3.53	4.4	-49.13
Capital Expenditures, 1 Yr. Growth %	-1.62	28.3	16.27	4.6	-23.42
Levered Free Cash Flow, 1 Yr. Growth %	-29.62	5.49	-127.51	-865.24	-53.26
Unlevered Free Cash Flow, 1 Yr. Growth %	-27.48	2.97	-83.04	1.26K	-39.49
Dividend Per Share, 1 Yr. Growth %	3.33	9.68	0.74	2.19	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.1	16.44	30.79	13.2	3.09
Gross Profit, 2 Yr. CAGR %	-19.03	29.23	35.67	-1.48	0.98
EBITDA, 2 Yr. CAGR %	-17.98	32.93	34.61	-13.05	-5.04
EBITA, 2 Yr. CAGR %	-23.72	41.15	44.06	-21.65	-12.61
EBIT, 2 Yr. CAGR %	-23.98	42.05	43.71	-25.02	-15.28
Earnings From Cont. Operations, 2 Yr. CAGR %	28.27	48.99	-2.37	1.42	-11.2
Net Income, 2 Yr. CAGR %	28.24	48.94	-2.32	1.84	-10.36
Normalized Net Income, 2 Yr. CAGR %	-23.4	37.33	31.79	-42.29	-26.74
Diluted EPS Before Extra, 2 Yr. CAGR %	37.21	57.35	1.65	2.72	-10.78
Accounts Receivable, 2 Yr. CAGR %	-11.75	16.87	31.95	3.47	-9.84
Inventory, 2 Yr. CAGR %	-3.31	21.17	69.45	24.36	-9.81
Net Property, Plant and Equip., 2 Yr. CAGR %	5.9	6.35	19.91	16.45	-2.84
Total Assets, 2 Yr. CAGR %	8.23	12.42	55.19	49.03	-6.73
Tangible Book Value, 2 Yr. CAGR %	12.35	34.97	65.79	37.51	-17.13
Common Equity, 2 Yr. CAGR %	8.7	29.26	26.44	30.11	-4.19
Cash From Operations, 2 Yr. CAGR %	-7.16	9.93	16.38	3.96	-27.13
Capital Expenditures, 2 Yr. CAGR %	3.93	12.35	22.14	10.28	-10.5
Levered Free Cash Flow, 2 Yr. CAGR %	-4.93	-13.67	-46.62	40.18	90.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.69	-13.44	-58.56	58.89	187.83
Dividend Per Share, 2 Yr. CAGR %	9.19	6.46	5.11	1.46	1.09
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-2.71	6.06	15.38	24.6	6.39
Gross Profit, 3 Yr. CAGR %	-5.06	10.79	14.01	26.27	-3.28
EBITDA, 3 Yr. CAGR %	-5.19	14.46	12.99	18.87	-9.45
EBITA, 3 Yr. CAGR %	-8.66	16.88	14.8	18.88	-16.49
EBIT, 3 Yr. CAGR %	-8.78	17.19	14.38	16.11	-18.96
Earnings From Cont. Operations, 3 Yr. CAGR %	32.47	16.34	30.27	-0.52	-7.74
Net Income, 3 Yr. CAGR %	33.04	16.12	30.51	-0.42	-6.96
Normalized Net Income, 3 Yr. CAGR %	-8.02	14.34	8.74	-5.33	-28.47
Diluted EPS Before Extra, 3 Yr. CAGR %	39.63	23.99	36.2	2.23	-6.69
Accounts Receivable, 3 Yr. CAGR %	-7.04	4.51	17.5	16.21	-1.16
Inventory, 3 Yr. CAGR %	2.81	13.37	39.34	34.07	14.44
Net Property, Plant and Equip., 3 Yr. CAGR %	3.5	6	15.26	12.92	8.52
Total Assets, 3 Yr. CAGR %	4.58	8.74	40.48	34.59	24.05
Tangible Book Value, 3 Yr. CAGR %	8.84	8.09	71.05	23.68	23.57
Common Equity, 3 Yr. CAGR %	6.89	11.97	31.01	26.22	7.3
Cash From Operations, 3 Yr. CAGR %	18.7	4.09	7.75	12.24	-18.08
Capital Expenditures, 3 Yr. CAGR %	10.88	11.49	13.64	15.99	-2.34
Levered Free Cash Flow, 3 Yr. CAGR %	1	-1.45	-41.39	26.74	-2.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	0.65	-2.09	-50	36.75	15.52
Dividend Per Share, 3 Yr. CAGR %	12.54	9.35	4.52	4.13	0.97
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.07	9.64	9.52	8.86	10.3
Gross Profit, 5 Yr. CAGR %	-0.38	13.8	9.51	5.71	8.61
EBITDA, 5 Yr. CAGR %	0.85	15.24	9.18	2.57	5.6
EBITA, 5 Yr. CAGR %	0.54	17.82	9.69	-0.37	3.05
EBIT, 5 Yr. CAGR %	0.36	17.78	9.41	-1.98	1.44
Earnings From Cont. Operations, 5 Yr. CAGR %	47.5	16.13	17.25	10.13	11.75
Net Income, 5 Yr. CAGR %	45.54	16	17.57	10.18	12.3
Normalized Net Income, 5 Yr. CAGR %	-0.83	16.73	6.22	-13.02	-7.15
Diluted EPS Before Extra, 5 Yr. CAGR %	53	22.48	22.98	15	15
Accounts Receivable, 5 Yr. CAGR %	2.33	7.71	6.94	4.1	5.69
Inventory, 5 Yr. CAGR %	7.48	16.18	25.55	17.64	17.08
Net Property, Plant and Equip., 5 Yr. CAGR %	2.94	4.37	9.77	10.06	7.65
Total Assets, 5 Yr. CAGR %	4.91	7.46	22.46	23.35	19.26
Tangible Book Value, 5 Yr. CAGR %	5.69	5.03	28.79	19.01	28.01
Common Equity, 5 Yr. CAGR %	8.2	10.11	14.32	18.9	15.6
Cash From Operations, 5 Yr. CAGR %	9.27	14.49	17.77	4.04	-7.85
Capital Expenditures, 5 Yr. CAGR %	-6.88	13.68	15.25	11.01	3.29
Levered Free Cash Flow, 5 Yr. CAGR %	28.51	3.67	-21.68	13.06	-7.4
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.05	2.78	-29.38	18.44	2.59
Dividend Per Share, 5 Yr. CAGR %	16.61	14.53	9.51	6.13	3.13